Cargando…

Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine

Detalles Bibliográficos
Autores principales: Hirano, Mitsuhito, Tamba, Mikako, Inoue, Norihito, Ikegami, Michiru, Onda, Naoki, Shirouchi, Yuko, Ishihara, Yuko, Abe, Hitoshi, Nishimura, Noriko, Mishima, Yuko, Takeuchi, Kengo, Maruyama, Dai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203379/
https://www.ncbi.nlm.nih.gov/pubmed/35187605
http://dx.doi.org/10.1007/s00277-022-04777-z
_version_ 1784728701871587328
author Hirano, Mitsuhito
Tamba, Mikako
Inoue, Norihito
Ikegami, Michiru
Onda, Naoki
Shirouchi, Yuko
Ishihara, Yuko
Abe, Hitoshi
Nishimura, Noriko
Mishima, Yuko
Takeuchi, Kengo
Maruyama, Dai
author_facet Hirano, Mitsuhito
Tamba, Mikako
Inoue, Norihito
Ikegami, Michiru
Onda, Naoki
Shirouchi, Yuko
Ishihara, Yuko
Abe, Hitoshi
Nishimura, Noriko
Mishima, Yuko
Takeuchi, Kengo
Maruyama, Dai
author_sort Hirano, Mitsuhito
collection PubMed
description
format Online
Article
Text
id pubmed-9203379
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-92033792022-06-18 Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine Hirano, Mitsuhito Tamba, Mikako Inoue, Norihito Ikegami, Michiru Onda, Naoki Shirouchi, Yuko Ishihara, Yuko Abe, Hitoshi Nishimura, Noriko Mishima, Yuko Takeuchi, Kengo Maruyama, Dai Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2022-02-21 2022 /pmc/articles/PMC9203379/ /pubmed/35187605 http://dx.doi.org/10.1007/s00277-022-04777-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Hirano, Mitsuhito
Tamba, Mikako
Inoue, Norihito
Ikegami, Michiru
Onda, Naoki
Shirouchi, Yuko
Ishihara, Yuko
Abe, Hitoshi
Nishimura, Noriko
Mishima, Yuko
Takeuchi, Kengo
Maruyama, Dai
Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine
title Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine
title_full Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine
title_fullStr Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine
title_full_unstemmed Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine
title_short Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine
title_sort durable response of therapy-related mds/aml with concomitant waldenström’s macroglobulinemia treated with venetoclax and azacitidine
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203379/
https://www.ncbi.nlm.nih.gov/pubmed/35187605
http://dx.doi.org/10.1007/s00277-022-04777-z
work_keys_str_mv AT hiranomitsuhito durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT tambamikako durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT inouenorihito durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT ikegamimichiru durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT ondanaoki durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT shirouchiyuko durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT ishiharayuko durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT abehitoshi durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT nishimuranoriko durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT mishimayuko durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT takeuchikengo durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine
AT maruyamadai durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine